Sage Therapeutics, Inc.·4

Jul 29, 7:59 PM ET

Kanes Stephen 4

4 · Sage Therapeutics, Inc. · Filed Jul 29, 2019

Insider Transaction Report

Form 4
Period: 2019-07-25
Kanes Stephen
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-07-25+1,9002,841 total
  • Tax Payment

    Common Stock

    2019-07-25$161.38/sh549$88,5982,292 total
Footnotes (1)
  • [F1]On February 13, 2019, the reporting person was granted Performance Stock Units (PSU) to acquire a total of 9,500 shares of common stock. The PSU vests upon the achievement of certain milestones, one of which was met on July 25, 2019, resulting in the vesting of the PSU as to 1,900 shares.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT